In:
Movement Disorders, Wiley, Vol. 19, No. 10 ( 2004-10), p. 1243-1244
Abstract:
We report on a case of reversible Pisa syndrome developed after treatment with galantamine in a patient with Alzheimer's disease without previous exposure to neuroleptic or other cholinesterase inhibitors. Complete and persistent resolution of the syndrome was achieved several weeks after botulinum toxin type‐A injection. © 2004 Movement Disorder Society
Type of Medium:
Online Resource
ISSN:
0885-3185
,
1531-8257
Language:
English
Publisher:
Wiley
Publication Date:
2004
detail.hit.zdb_id:
2041249-6
